Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: BREAST CANCER, . Treffer: 594
2025
Banys-Paluchowski, M; Hartmann, S; Basali, T; Gasparri, ML; de, Boniface, J; Gentilini, OD; Cakmak, GK; Ditsch, N; Stickeler, E; Schlichting, E; Rubio, I; Peintinger, F; Untch, M; Mau, C; Federspiel, FK; Bucher, S; Ramaker, K; Paluchowski, P; Bauer, L; Riemer, S; Langanke, D; Leuf, TD; Schnabel, J; von, Abel, E; Solbach, C; Ovalle, SC; Hilmer, K; Bjelic-Radisic, V; Stahl, N; Sanchez-Mendez, JI; Hagen, V; Hansen, MH; Krawczyk, N; Sezen, BA; Jursik, K; Thill, M; Kolberg, HC; Reimer, T; Ruf, F; Wihlfahrt, K; Rief, A; Berger, T; Schmidt, E; Tauber, N; Fröhlich, S; Kühn, T
Radar reflectors for marking of target lymph nodes in initially node-positive patients receiving neoadjuvant chemotherapy for breast cancer-a subgroup analysis of the prospective AXSANA (EUBREAST-03) trial.
Breast Cancer Res Treat. 2025;
Doi: 10.1007/s10549-025-07635-4
Web of Science
PubMed
FullText
FullText_MUG
Bjelic-Radisic, V; Cardoso, F; Weis, J; Pogoda, K; Arraras, JI; Greimel, E; Bottomley, A; Cameron, D; Brain, E; Hartup, S; Da, Costa, Vieira, RA; Hoefnagels, N; Huang, CS; Shamieh, O; Pinto, M; Belay, YB; Serpentini, S; Bleiker, E; Nookala, M; Shimomura, A; Sturm-Inwald, E; Getu, MA; Bliem, B; Astrup, G; Morag, O; Kikawa, Y; Kuljanic, K; Nevries, N; Sprangers, M; Aaronson, N; Sinai, P; Tomaszweski, K; Galalae, R; Conroy, T; Duhoux, F; Chie, WC; Velikova, G, , EORTC, Quality, of, Life, Group, and, Breast, Cancer, Group
An international Phase IV field study - psychometric properties of the updated module on assessing quality of life of patients with breast cancer EORTC QLQ-BR42.
Breast. 2025; 80:103890
Doi: 10.1016/j.breast.2025.103890
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Dagnino, F; Pohl, KK; Qian, Z; Zurl, H; Stelzl, D; Korn, SM; Lughezzani, G; Buffi, NM; Kibel, AS; Trinh, QD; Cole, AP
Association of Cannabis Use With Guideline-Recommended Cancer Screenings: Results From a National Health Behaviors Survey.
JCO Oncol Pract. 2025; OP2401093
Doi: 10.1200/OP-24-01093
PubMed
FullText
FullText_MUG
DeMichele, A; Dueck, AC; Hlauschek, D; Martin, M; Burstein, H; Pfeiler, G; Zdenkowski, N; Wolff, A; Bellet-Ezquerra, M; Winer, E; Balic, M; Miller, K; Colleoni, M; Lake, D; Rubovsky, G; Cameron, D; Balko, J; Singer, CF; Nowecki, Z; Iwata, H; Wolmark, N; Parraga, KA; Rugo, H; Steger, GG; Traina, T; Werutsky, G; Czajkowska, D; Metzger, O; El-Abed, S; Theall, KP; Lu, RD; O'Brien, P; Fesl, C; Mayer, E; Gnant, M
Outcomes in stage IIA versus stage IIB/III in the PALLAS trial [ABCSG-42/AFT-05/PrE0109/BIG-14-13]).
Breast Cancer Res. 2025; 27(1):12
Doi: 10.1186/s13058-024-01941-3
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Flores, T; Jaklin, FJ; Mayrl, MS; Kerschbaumer, C; Glisic, C; Pfoser, K; Lumenta, DB; Schrögendorfer, KF; Hörmann, C; Bergmeister, KD
Paravertebral Blocks in Implant-Based Breast Reconstruction Do Not Induce Increased Postoperative Blood or Drainage Fluid Loss.
J Clin Med. 2025; 14(6):
Doi: 10.3390/jcm14061832
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Gampenrieder, SP; Vaisband, M; Rinnerthaler, G; Weiss, L; Jaud, B; Sprenger, M; Greil, R
A comparison of breast cancer incidence and cancer stages before and after the introduction of the Austrian national breast cancer screening program in the federal state of Salzburg : Real-world data from the Tumor Registry Salzburg.
Wien Klin Wochenschr. 2025;
Doi: 10.1007/s00508-025-02508-8
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Klocker, EV; Egle, D; Bartsch, R; Rinnerthaler, G; Gnant, M
Efficacy and Safety of CDK4/6 Inhibitors: A Focus on HR+/HER2- Early Breast Cancer.
Drugs. 2025;
Doi: 10.1007/s40265-024-02144-y
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Naughton, MJ; Zahrieh, DM; Gnant, M; Zdenkowski, N; Lemieux, J; Mao, JJ; Bjelic-Radisic, V; Shinn, E; Balic, M; Thomssen, C; Meisel, JL; Ruiz, GM; Loibl, S; Isaacs, C; Cameron, D; Henao-Carrasco, FM; Goetz, MP; Singer, CF; Werutsky, G; Rugo, HS; Vetter, M; Tseng, LM; Miller, K; Fitzal, F; Gil, Gil, JM; Park, H; Linderholm, B; Bajetta, E; Dayao, Z; Prat, A; Ehrhardt, K; Metzger, O; Arahmani, A; Law, EH; Partridge, AH; Carey, LA; Zoroufy, A; Dueck, AC; O'Brien, P; Hlauschek, D; DeMichele, A; Mayer, EL
Quality-of-life and symptom severity in the PALLAS randomized trial of palbociclib with adjuvant endocrine therapy in early breast cancer (AFT-05, ABCSG-42, BIG-14-03, PrE0109).
ESMO Open. 2025; 10(6):105120
Doi: 10.1016/j.esmoop.2025.105120
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Niedermayer, K; Schäffler, H; Vlachos, G; Greco, S; Pfister, K; Volz, B; Ott, L; Neubauer, H; Polzer, B; Koch, A; Riethdorf, S; Fehm, T; Janni, W; Friedl, TWP; Rack, B; Heitzer, E; Schochter, F; Wiesmüller, L
Mass cytometric detection of homologous recombination proficiency in circulating tumor cells to predict chemoresistance of metastatic breast cancer patients.
Int J Cancer. 2025;
Doi: 10.1002/ijc.35498
Web of Science
PubMed
FullText
FullText_MUG
Rinnerthaler, G; Egle, D; Bartsch, R; Schmitt, CA; Petzer, A; Balic, M; Petru, E; Denison, U; Singer, CF; Bjelic-Radisic, V; Gampenrieder, SP; Knauer, M; Sotlar, K; Brunner, C; Posch, F; Hlauschek, D; Sölkner, L; Bago-Horvath, Z; Filipits, M; Gili, M; Ritter, M; Wieser, V; Albertini, C; Zaborsky, N; Weiss, L; Marhold, M; Schneeweiss, B; Pusch, R; Gnant, M; Greil, R
Neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in women with early HER2-positive breast cancer: the randomized phase 2 ABCSG-52/ATHENE trial.
Nat Cancer. 2025;
Doi: 10.1038/s43018-024-00890-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Shinn, E; Zahrieh, D; DeMichele, A; Zdenkowski, N; Lemieux, J; Mao, J; Bjelic-Radisic, V; Naughton, MJ; Pfeiler, G; Gelmon, K; Balko, JM; Egle, D; Zoppoli, G; Traina, T; Jimenez, MM; Novoa, SA; Haddad, T; Chan, A; Ring, A; Wolff, A; Symmans, WF; Ponce, Lorenzo, J; Sabanathan, D; Burstein, HJ; Nowecki, ZI; Pristauz-Telsnigg, G; Brufsky, A; Bellet-Ezquerra, M; Foukakis, T; Novik, Y; Rubovszky, G; Singer, CF; Muehlbacher, K; Filho, OM; Goulioti, T; Law, E; Partridge, AH; Carey, LA; Zoroufy, A; Hlauschek, D; Fesl, C; Mayer, EL; Gnant, M
Impact of adding palbociclib on treatment adherence to ongoing adjuvant endocrine treatment in the global randomized PALLAS randomized trial in patients with early breast cancer.
Breast Cancer Res Treat. 2025;
Doi: 10.1007/s10549-025-07653-2
Web of Science
PubMed
FullText
FullText_MUG
Wenzel, M; Hoeh, B; Koll, F; Humke, C; Fassl, A; Reis, H; Wild, P; Steuber, T; Graefen, M; Tilki, D; Traumann, M; Banek, S; Chun, FKH; Mandel, P
Impact of homologous recombination repair/BReast CAncer (BRCA) gene alterations on survival in a real-world setting of metastatic prostate cancer.
BJU Int. 2025; 135(1): 117-124.
Doi: 10.1111/bju.16462
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Wimmer, K; Hlauschek, D; Balic, M; Pfeiler, G; Greil, R; Singer, CF; Halper, S; Steger, G; Suppan, C; Gampenrieder, SP; Helfgott, R; Egle, D; Filipits, M; Jakesz, R; Sölkner, L; Fesl, C; Gnant, M; Fitzal, F, , Austrian, Breast, &, Colorectal, Cancer, Study, Group
Validation of the CTS5 in four prospective, multicenter, randomized ABCSG trials.
Breast. 2025; 80:104415
Doi: 10.1016/j.breast.2025.104415
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2024
Azim, HA; Niman, SM; Partridge, AH; Demeestere, I; Ruggeri, M; Colleoni, M; Saura, C; Shimizu, C; Saetersdal, AB; Kroep, JR; Mailliez, A; Warner, E; Borges, VF; Amant, F; Gombos, A; Kataoka, A; Rousset-Jablonski, C; Borstnar, S; Takei, J; Lee, JE; Walshe, JM; Ruíz-Borrego, M; Moore, HCF; Saunders, C; Bjelic-Radisic, V; Susnjar, S; Cardoso, F; Klar, NJ; Spanic, T; Ruddy, K; Piccart, M; Korde, LA; Goldhirsch, A; Gelber, RD; Pagani, O; Peccatori, FA
Fertility Preservation and Assisted Reproduction in Patients With Breast Cancer Interrupting Adjuvant Endocrine Therapy to Attempt Pregnancy.
J Clin Oncol. 2024; JCO2302292
Doi: 10.1200/JCO.23.02292
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Bartsch, R; Rinnerthaler, G; Petru, E; Egle, D; Gnant, M; Balic, M; Sliwa, T; Singer, C
Updated Austrian treatment algorithm for metastatic triple-negative breast cancer.
Wien Klin Wochenschr. 2024; 136(11-12):347-361
Doi: 10.1007/s00508-023-02254-9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Bischof, H; Maier, S; Koprowski, P; Kulawiak, B; Burgstaller, S; Jasińska, J; Serafimov, K; Zochowska, M; Gross, D; Schroth, W; Matt, L; Juarez, Lopez, DA; Zhang, Y; Bonzheim, I; Büttner, FA; Fend, F; Schwab, M; Birkenfeld, AL; Malli, R; Lämmerhofer, M; Bednarczyk, P; Szewczyk, A; Lukowski, R
mitoBKCa is functionally expressed in murine and human breast cancer cells and potentially contributes to metabolic reprogramming.
Elife. 2024; 12: RP92511
Doi: 10.7554/eLife.92511
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Freyer, G; Martinez-Jañez, N; Kukielka-Budny, B; Ulanska, M; Bourgeois, H; Muñoz, M; Morales, S; Calero, JB; Cortesi, L; Pintér, T; Palácová, M; Cherciu, N; Petru, E; Ettl, J; de, Almeida, C; Villanova, G; Raymond, R; Minh, CTT; Rodrigues, A; Cazzaniga, ME
Single-agent metronomic versus weekly oral vinorelbine as first-line chemotherapy in patients with HR-positive/HER2-negative advanced breast cancer: The randomized Tempo Breast study.
Breast. 2024; 74:103681
Doi: 10.1016/j.breast.2024.103681
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Girolami, I; Kluge, RW; Gallmetzer, L; Albi, C; Sorgi, P; Dejaco, C; Tauber, M; Hanspeter, E; Matzneller, P
Multicentric reticulohistiocytosis with oral and laryngeal involvement in association with autoimmune/inflammatory syndrome induced by adjuvants (ASIA): expanding the spectrum of two uncommon entities.
Mod Rheumatol Case Rep. 2024;
Doi: 10.1093/mrcr/rxae040
Web of Science
PubMed
FullText
FullText_MUG
Gnant, M; Balic, M; Singer, CF; Rinnerthaler, G; Pfeiler, G; Suppan, C; Grünberger, B; Strasser-Weippl, K; Castagnaviz, V; Heibl, S; Bartsch, R
Evolving treatment paradigms after CDK4/6 inhibitors in advanced breast cancer
MEMO-MAG EUR MED ONC. 2024;
Doi: 10.1007/s12254-024-01012-5
Web of Science
FullText
FullText_MUG
Harbeck, N; Wrobel, D; Zaiss, M; Terhaag, J; Guth, D; Distelrath, A; Zahn, MO; Wuerstlein, R; Lorenz, A; Bartsch, R; Breitenstein, U; Schwitter, M; Balic, M; Jackisch, C; Müller, V; Rinnerthaler, G; Schmidt, M; Zaman, K; Schinköthe, T; Resch, A; Valenti, R; Lüftner, D
Neratinib as Extended Adjuvant Treatment of HER2-Positive/HR-Positive Early Breast Cancer Patients in Germany, Austria, and Switzerland: Interim Results of the Prospective, Observational ELEANOR Study.
Breast Care (Basel). 2024; 19(1):1-9
Doi: 10.1159/000533657
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
Huemer, M; Graca, S; Bitsche, S; Hofmann, G; Armour, M; Pichler, M
Mapping the clinical practice of traditional, complementary and integrative medicine in oncology in Western countries: A multinational cross-sectional survey.
J Integr Med. 2024; 22(1):64-71
Doi: 10.1016/j.joim.2023.12.002
Web of Science
PubMed
FullText
FullText_MUG
Jonas, K; Prinz, F; Ferracin, M; Krajina, K; Deutsch, A; Madl, T; Rinner, B; Slaby, O; Klec, C; Pichler, M
MiR-4646-5p Acts as a Tumor-Suppressive Factor in Triple Negative Breast Cancer and Targets the Cholesterol Transport Protein GRAMD1B.
Noncoding RNA. 2023; 10(1):
Doi: 10.3390/ncrna10010002
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Klocker, EV; Hasenleithner, S; Bartsch, R; Gampenrieder, SP; Egle, D; Singer, CF; Rinnerthaler, G; Hubalek, M; Schmitz, K; Bago-Horvath, Z; Petzer, A; Heibl, S; Heitzer, E; Balic, M; Gnant, M
Clinical applications of next-generation sequencing-based ctDNA analyses in breast cancer: defining treatment targets and dynamic changes during disease progression.
Mol Oncol. 2024;
Doi: 10.1002/1878-0261.13671
Web of Science
PubMed
FullText
FullText_MUG
Klocker, EV; Suppan, C
Liquid biopsy in breast cancer
MEMO-MAG EUR MED ONC. 2024;
Doi: 10.1007/s12254-024-00975-9
Web of Science
FullText
FullText_MUG
Knabl, J; Ye, Y; Desoye, G; Jeschke, U
HLA-G - evolvement from a trophoblast specific marker to a checkpoint molecule in cancer, a narrative review about the specific role in breast- and gynecological cancer.
J Reprod Immunol. 2024; 166:104385
Doi: 10.1016/j.jri.2024.104385
Web of Science
PubMed
FullText
FullText_MUG
Kuryk, L; Mathlouthi, S; Wieczorek, M; Gad, B; Rinner, B; Malfanti, A; Mastrotto, F; Salmaso, S; Caliceti, P; Garofalo, M
Priming with oncolytic adenovirus followed by anti-PD-1 and paclitaxel treatment leads to improved anti-cancer efficacy in the 3D TNBC model.
Eur J Pharm Biopharm. 2024; 114300
Doi: 10.1016/j.ejpb.2024.114300
Web of Science
PubMed
FullText
FullText_MUG
Marcon, M; Fuchsjäger, MH; Clauser, P; Mann, RM
ESR Essentials: screening for breast cancer - general recommendations by EUSOBI.
EUR RADIOL. 2024; 34(10): 6348-6357.
Doi: 10.1007/s00330-024-10740-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Matikas, A; Möbus, V; Greil, R; Andersson, A; Steger, GG; Untch, M; Fornander, T; Malmström, P; Schmatloch, S; Johansson, H; Hellström, M; Brandberg, Y; Gnant, M; Loibl, S; Foukakis, T; Bergh, J, , SweBCG, ABCSG, and, GBG
Tailored Dose-Dense Versus Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer: End-of-Study Results of the Randomized PANTHER Trial.
J Clin Oncol. 2024; 42(26):3077-3082
Doi: 10.1200/JCO.24.00178
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Nader-Marta, G; Singer, C; Hlauschek, D; DeMichele, A; Tarantino, P; de Azambuja, E; Pfeiler, G; Martin, M; Balko, JM; Nowecki, Z; Balic, M; Brufsky, AM; Chan, ARE; Morris, PG; Haddad, T; Loibl, S; Liu, Y; Soelkner, L; Fesl, C; Mayer, EL; Gnant, M
Clinical characterization, prognostic, and predictive values of HER2-low in patients with early breast cancer in the PALLAS trial (ABCSG-42/AFT-05/BIG-14-13/PrE0109)
BREAST CANCER RES. 2024; 26(1): 140
Doi: 10.1186/s13058-024-01899-2
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Parrella, P; Barbano, R; Jonas, K; Fontana, A; Barile, S; Rendina, M; lo Mele, A; Prencipe, G; Ciuffreda, L; Morritti, MG; Valori, VM; Graziano, P; Maiello, E; Copetti, M; Pichler, M; Pasculli, B
Tumor Suppressor miR-27a-5p and Its Significance for Breast Cancer
BIOMEDICINES. 2024; 12(11): 2625
Doi: 10.3390/biomedicines12112625
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Rubio, IT; Marotti, L; Biganzoli, L; Aristei, C; Athanasiou, A; Campbell, C; Cardoso, F; Cardoso, MJ; Coles, CE; Eicher, M; Harbeck, N; Karakatsanis, A; Offersen, BV; Pijnappel, R; Ponti, A; Regitnig, P; Santini, D; Sardanelli, F; Spanic, T; Varga, Z; Vrancken, Peeters, MJTFD; Wengström, Y; Wyld, L; Curigliano, G
EUSOMA quality indicators for non-metastatic breast cancer: An update.
Eur J Cancer. 2023; 198: 113500
Doi: 10.1016/j.ejca.2023.113500
Web of Science
PubMed
FullText
FullText_MUG
Rubio, IT; Wyld, L; Marotti, L; Athanasiou, A; Regitnig, P; Catanuto, G; Schoones, Ma, JW; Zambon, M; Camps, J; Santini, D; Dietz, J; Sardanelli, F; Varga, Z; Smidt, M; Sharma, N; Shaaban, AM; Gilbert, F
European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO.
Eur J Surg Oncol. 2023; 50(1):107292
Doi: 10.1016/j.ejso.2023.107292
Web of Science
PubMed
FullText
FullText_MUG
Ruhe, L; Heibl, S; Czompo, M; Haybaeck, J; Loskutov, J; Regenbrecht, MJ; Thaler, J; Wedeken, L; Alexander, Regenbrecht, CR
Functional Precision Medicine Successfully Guides Therapeutic Regimen of 'Cancer of Unknown Primary' Later Classified as Triple-Negative Breast Cancer: A Case Report.
Case Rep Oncol. 2024; 17(1): 490-496.
Doi: 10.1159/000538137
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Sunitsch, S; Fischer, P; Pregartner, G; Regitnig, P
The misunderstanding of the R Classification-a survey amongst medical specialties treating breast cancer.
Virchows Arch. 2024;
Doi: 10.1007/s00428-024-03876-8
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Tawfik, I; Schlick, K; Ostaku, J; Bresilla, D; Gabrijelčič, S; Gottschalk, B; Sokolowski, A; Malle, E; Kalinova, K; Hirtl, M; Madreiter-Sokolowski, CT
Breast cancer cells utilize T3 to trigger proliferation through cellular Ca2+ modulation.
Cell Commun Signal. 2024; 22(1): 533
Doi: 10.1186/s12964-024-01917-y
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Thomassin-Naggara, I; Athanasiou, A; Kilburn-Toppin, F; Forrai, G; Ispas, M; Lesaru, M; Giannotti, E; Pinker-Domenig, K; Van Ongeval, C; Mann, RM; Gilbert, F; Pediconi, F; Athanasiou, A; Baltzer, P; Herrero, JC; Clauser, P; Forrai, G; Gilbert, FJ; Fuchsjäger, M; Giannotti, E; Helbich, T; Kilburn-Toppin, F; Kuhl, CK; Fallenberg, EM; Lesaru, M; Mann, RM; Pijnappel, R; Pinker-Domenig, K; Van Ongeval, C; Pediconi, F; Sardanelli, F; Sella, T; Thomassin-Naggara, I; Zackrisson, S
Misdiagnosis in breast imaging: a statement paper from European Society Breast Imaging (EUSOBI)-Part 2: Main causes of errors in breast imaging and recommendations from European Society of Breast Imaging to limit misdiagnosis
EUR RADIOL. 2024;
Doi: 10.1007/s00330-024-11133-4
Web of Science
PubMed
FullText
FullText_MUG
Tiodorovic, D; Stojkovic-Filipovic, J; Marghoob, A; Argenziano, G; Puig, S; Malvehy, J; Tognetti, L; Pietro, R; Akay, BN; Zalaudek, I; Haenssle, HA; Müller-Christmann, C; Cinotti, E; Perrot, JL; Zaballos, P; Bakos, RM; Thomas, L; Peris, K; Lallas, A; Apalla, Z; Kreusch, JF; Tromme, I; Stratigos, AJ; Pizzichetta, MA; Kandolf, L; Longo, C; Blum, A; Tanaka, M; Hofmann-Wellenhof, R; Jovic, A; Paoli, J; Buljan, M; Espasandín-Arias, M; Cabo, H; Saa, SR; Salerni, G; Nazzaro, G; Kaminska-Winciorek, G; Damiani, G; Geszti, F; Kittler, H, , IDS, Study, group
Dermatoscopic patterns of cutaneous metastases: A multicentre cross-sectional study of the International Dermoscopy Society.
J Eur Acad Dermatol Venereol. 2024;
Doi: 10.1111/jdv.19962
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Wenzel, M; Koll, F; Hoeh, B; Humke, C; Reis, H; Wild, P; Steuber, T; Graefen, M; Tilki, D; Sabet, A; Gröner, D; Chun, FKH; Mandel, P
Cancer-Control Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer With BRCA Gene or Tumor Suppressor Mutations Undergoing 177-Lutetium Prostate-Specific Membrane Antigen Radioligand Therapy.
JCO Precis Oncol. 2024; 8: e2400645
Doi: 10.1200/PO-24-00645
Web of Science
PubMed
FullText
FullText_MUG
Wimmer, K; Hlauschek, D; Balic, M; Pfeiler, G; Singer, CF; Halper, S; Steger, G; Suppan, C; Gampenrieder, SP; Helfgott, R; Egle, D; Filipits, M; Jakesz, R; Sölkner, L; Fesl, C; Gnant, M; Fitzal, F; Greil, R
Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?
BREAST CANCER RES TR. 2024;
Doi: 10.1007/s10549-023-07186-6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Zhang, Y; Chen, F; Balic, M; Creighton, CJ
An essential gene signature of breast cancer metastasis reveals targetable pathways.
Breast Cancer Res. 2024; 26(1):98
Doi: 10.1186/s13058-024-01855-0
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2023
Balic, M; Thomssen, C; Gnant, M; Harbeck, N
St. Gallen/Vienna 2023: Optimization of Treatment for Patients with Primary Breast Cancer - A Brief Summary of the Consensus Discussion.
Breast Care (Basel). 2023; 18(3):213-222
Doi: 10.1159/000530584
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Beltran-Bless, AA; Clemons, MJ; Fesl, C; Greil, R; Pond, GR; Balic, M; Vandermeer, L; Bjelic-Radisic, V; Singer, CF; Steger, GG; Helfgott, R; Egle, D; Sölkner, L; Gampenrieder, SP; Kacerovsky-Strobl, S; Suppan, C; Ritter, M; Rinnerthaler, G; Pfeiler, G; Fohler, H; Hlauschek, D; Hilton, J; Gnant, M
Does the number of 6-monthly adjuvant zoledronate infusions received affect treatment efficacy for early breast cancer? A sub-study of ABCSG-12.
Eur J Cancer. 2023; 180:108-116
Doi: 10.1016/j.ejca.2022.12.003
Web of Science
PubMed
FullText
FullText_MUG
Brcic, I; Kluba, AM; Godschachner, TM; Suppan, C; Regitnig, P; Dandachi, N; Lax, SF; Balić, M
Tumor Microenvironment in Male Breast Carcinoma with Emphasis on Tumor Infiltrating Lymphocytes and PD-L1 Expression.
Int J Mol Sci. 2023; 24(1):
Doi: 10.3390/ijms24010818
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Cserni, B; Kilmartin, D; O'Loughlin, M; Andreu, X; Bagó-Horváth, Z; Bianchi, S; Chmielik, E; Figueiredo, P; Floris, G; Foschini, MP; Kovács, A; Heikkilä, P; Kulka, J; Laenkholm, AV; Liepniece-Karele, I; Marchiò, C; Provenzano, E; Regitnig, P; Reiner, A; Ryška, A; Sapino, A; Stovgaard, ES; Quinn, C; Zolota, V; Webber, M; Glynn, SA; Bori, R; Csörgő, E; Oláh-Németh, O; Pancsa, T; Sejben, A; Sejben, I; Vörös, A; Zombori, T; Nyári, T; Callagy, G; Cserni, G
ONEST (Observers Needed to Evaluate Subjective Tests) Analysis of Stromal Tumour-Infiltrating Lymphocytes (sTILs) in Breast Cancer and Its Limitations.
Cancers (Basel). 2023; 15(4):
Doi: 10.3390/cancers15041199
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Frohlich, E
The Variety of 3D Breast Cancer Models for the Study of Tumor Physiology and Drug Screening
INT J MOL SCI. 2023; 24(8): 7116
Doi: 10.3390/ijms24087116
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Gampenrieder, SP; Dezentjé, V; Lambertini, M; de, Nonneville, A; Marhold, M; Le, Du, F; Cortés, Salgado, A; Alpuim, Costa, D; Vaz, Batista, M; Chic, Ruché, N; Tinchon, C; Petzer, A; Blondeaux, E; Del, Mastro, L; Targato, G; Bertucci, F; Gonçalves, A; Viret, F; Bartsch, R; Mannsbart, C; Deleuze, A; Robert, L; Saavedra, Serrano, C; Gion, Cortés, M; Sampaio-Alves, M; Vitorino, M; Pecen, L; Singer, C; Harbeck, N; Rinnerthaler, G; Greil, R, , AGMT, Study, Group
Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer-results from an international, multicenter analysis coordinated by the AGMT Study Group.
ESMO Open. 2023; 8(1):100747
Doi: 10.1016/j.esmoop.2022.100747
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Gnant, M; Singer, CF; Rinnerthaler, G; Pfeiler, G; Egle, D; Balic, M; Bartsch, R
Position paper on CDK4/6 inhibitors in early breast cancer
MEMO-MAG EUR MED ONC. 2023;
Doi: 10.1007/s12254-023-00878-1
Web of Science
FullText
FullText_MUG
Gold, D; Nicolay, L; Avian, A; Greimel, E; Balic, M; Pristauz-Telsnigg, G; Tamussino, K; Trutnovsky, G
Vaginal laser therapy versus hyaluronic acid suppositories for women with symptoms of urogenital atrophy after treatment for breast cancer: A randomized controlled trial.
Maturitas. 2023; 167: 1-7.
Doi: 10.1016/j.maturitas.2022.08.013
Web of Science
PubMed
FullText
FullText_MUG
Grant, WB; Al, Anouti, F; Boucher, BJ; Fakhoury, HMA; Moukayed, M; Pilz, S; Al-Daghri, NM
Evidence That Increasing Serum 25(OH)D Concentrations to 30 ng/mL in the Kingdom of Saudi Arabia and the United Arab Emirates Could Greatly Improve Health Outcomes.
Biomedicines. 2023; 11(4):
Doi: 10.3390/biomedicines11040994
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Harbeck, N; Wrobel, D; Zaiss, M; Terhaag, J; Guth, D; Distelrath, A; Zahn, MO; Wuerstlein, R; Lorenz, A; Bartsch, R; Breitenstein, U; Schwitter, M; Balic, M; Jackisch, C; Mueller, V; Rinnerthaler, G; Schmidt, M; Zaman, K; Schinköthe, T; Resch, A; Valenti, R; Lüftner, D
Neratinib as extended adjuvant treatment of HER2-positive/HR-positive early breast cancer patients in Germany, Austria and Switzerland: interim results of the prospective, observational ELEANOR study
BREAST CARE. 2023;
Doi: 10.1159/000533657
Web of Science
FullText
FullText_MUG
Weitere 50 Treffer anzeigen